Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 21,153 | 70,592 | -45,411 | -86,420 | -107,373 |
| Depreciation Amortization | 13,081 | 8,206 | 3,963 | 6,520 | 5,277 |
| Accounts receivable | 44,459 | 57,231 | 57,661 | -55,232 | -14,735 |
| Accounts payable and accrued liabilities | -5,084 | -5,079 | -5,367 | 3,630 | 4,622 |
| Other Working Capital | -116,666 | -118,973 | 47,677 | -48,398 | 4,990 |
| Other Operating Activity | 9,402 | -18,149 | -36,043 | 103,756 | 48,540 |
| Operating Cash Flow | $-33,655 | $-6,172 | $22,480 | $-76,144 | $-58,679 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -155,932 | -105,511 | -76,004 | -576,880 | -110,156 |
| PPE Investments | -4,017 | -2,206 | -483 | -7,836 | -4,668 |
| Sale Of Investment | 305,000 | 100,000 | 50,000 | 62,593 | 55,557 |
| Investing Cash Flow | $145,051 | $-7,717 | $-26,487 | $-522,123 | $-59,267 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 49 | 49 |
| Debt Repayment | -9,112 | -6,052 | -3,118 | -409 | -302 |
| Common Stock Issued | 15,710 | 13,337 | 5,572 | 29,847 | 24,598 |
| Other Financing Activity | -10,614 | -8,065 | -5,988 | -15,612 | -13,288 |
| Financing Cash Flow | $-4,016 | $-780 | $-3,534 | $13,875 | $11,057 |
| Exchange Rate Effect | -46 | -2 | -44 | -8 | -47 |
| Beginning Cash Position | 89,258 | 89,258 | 89,258 | 673,658 | 673,658 |
| End Cash Position | 196,592 | 74,587 | 81,673 | 89,258 | 566,722 |
| Net Cash Flow | $107,334 | $-14,671 | $-7,585 | $-584,400 | $-106,936 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,655 | -6,172 | 22,480 | -76,144 | -58,679 |
| Capital Expenditure | -4,017 | -2,206 | -483 | -8,020 | -4,852 |
| Free Cash Flow | -37,672 | -8,378 | 21,997 | -84,164 | -63,531 |